US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 63.420
  • -2.180-3.32%
Close Nov 15 16:00 ET
  • 63.420
  • 0.0000.00%
Post 20:01 ET
12.09BMarket Cap38.20P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
28.28%745.74M
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
13.53%2.1B
19.50%537.54M
Operating revenue
28.28%745.74M
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
13.53%2.1B
19.50%537.54M
Cost of revenue
47.18%188.46M
-0.12%130.46M
-7.60%125.18M
6.45%514.85M
-5.16%120.72M
10.11%128.04M
6.09%130.62M
15.82%135.47M
2.80%483.67M
6.30%127.29M
Gross profit
22.94%557.28M
25.16%581.57M
13.60%523.65M
18.11%1.9B
28.09%525.49M
16.51%453.29M
13.15%464.66M
14.55%460.94M
17.20%1.61B
24.29%410.25M
Operating expense
16.81%443.41M
15.54%461.12M
11.71%445.19M
11.48%1.75B
21.13%525.88M
-2.80%379.6M
7.68%399.09M
7.40%398.54M
8.02%1.57B
10.11%434.15M
Selling and administrative expenses
46.87%253.5M
27.62%263.03M
7.05%225.91M
9.75%937.3M
23.89%304.4M
-20.39%172.6M
4.71%206.1M
8.43%211.02M
12.46%854M
12.91%245.7M
-Selling and marketing expense
-10.66%108.9M
6.23%122.8M
----
8.46%488.4M
6.90%133.2M
9.52%121.9M
5.67%115.6M
----
11.16%450.3M
10.17%124.6M
-General and administrative expense
185.21%144.6M
54.95%140.23M
----
11.20%448.9M
41.37%171.2M
-51.94%50.7M
3.51%90.5M
----
13.94%403.7M
15.89%121.1M
Research and development costs
-3.35%184.9M
3.62%183.79M
19.29%204.99M
14.96%746.77M
19.39%206.25M
21.22%191.31M
12.12%177.36M
6.85%171.85M
3.31%649.61M
7.24%172.75M
Depreciation amortization depletion
-68.06%5.01M
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.03%15.23M
-1.38%15.68M
0.19%15.62M
0.37%15.67M
1.45%62.8M
0.64%15.7M
-Depreciation and amortization
-68.06%5.01M
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.03%15.23M
-1.38%15.68M
0.19%15.62M
0.37%15.67M
1.45%62.8M
0.64%15.7M
Operating profit
54.52%113.87M
83.71%120.45M
25.73%78.46M
243.96%158.1M
98.37%-390K
5,102.92%73.69M
63.70%65.57M
99.20%62.4M
161.84%45.96M
62.79%-23.9M
Net non-operating interest income expense
26.12%15.09M
83.03%16.21M
91.97%15.82M
1,886.63%41M
134.97%11.95M
3,637.81%11.96M
754.14%8.86M
514.90%8.24M
142.51%2.06M
341.98%5.08M
Non-operating interest income
14.70%18.05M
56.87%19.79M
62.15%19.37M
223.49%58.34M
107.16%18.04M
214.86%15.74M
403.47%12.61M
556.21%11.94M
72.05%18.03M
399.14%8.71M
Non-operating interest expense
-21.46%2.97M
-4.82%3.57M
-4.21%3.55M
8.87%16.74M
81.47%5.5M
-19.23%3.78M
-2.69%3.76M
-2.71%3.7M
4.29%15.38M
-6.76%3.03M
Total other finance cost
----
----
----
0.17%594K
----
----
----
----
0.00%593K
----
Other net income (expense)
768.67%5.46M
-25.30%-4.53M
181.13%11.27M
-110.38%-10.54M
518.36%7.78M
-15.56%-817K
6.08%-3.61M
-113.25%-13.89M
2,540.41%101.55M
529.35%1.26M
Special income (charges)
--0
--0
--10M
--0
--0
--0
--0
--0
1,395.00%103.6M
64.71%-600K
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
-45.00%4.4M
-64.71%600K
-Gain on sale of property,plant,equipment
--0
--0
--10M
--0
--0
--0
--0
--0
--108M
--0
Other non- operating income (expenses)
768.67%5.46M
-25.30%-4.53M
109.12%1.27M
-414.05%-10.54M
318.68%7.78M
-523.32%-817K
-22.60%-3.61M
-1,103.38%-13.89M
-117.31%-2.05M
32.05%1.86M
Income before tax
222.64%134.44M
86.61%132.14M
85.96%105.55M
26.07%188.56M
210.08%19.33M
2,288.50%41.67M
103.18%70.81M
-57.70%56.76M
298.51%149.58M
73.63%-17.56M
Income tax
2,096.82%28.36M
69.00%24.96M
185.94%16.89M
160.99%20.92M
93.95%-1.05M
-72.81%1.29M
105.51%14.77M
-55.90%5.91M
171.12%8.02M
-99.50%-17.31M
Net income
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
Net income continuous Operations
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
Minority interest income
Net income attributable to the parent company
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
Basic earnings per share
166.67%0.56
86.67%0.56
74.07%0.47
17.11%0.89
8,315.09%0.11
625.00%0.21
100.00%0.3
-59.09%0.27
317.14%0.76
99.58%-0.0013
Diluted earnings per share
161.90%0.55
89.66%0.55
70.37%0.46
16.00%0.87
8,315.09%0.11
625.00%0.21
93.33%0.29
-57.14%0.27
314.29%0.75
99.58%-0.0013
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 28.28%745.74M19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M13.53%2.1B19.50%537.54M
Operating revenue 28.28%745.74M19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M13.53%2.1B19.50%537.54M
Cost of revenue 47.18%188.46M-0.12%130.46M-7.60%125.18M6.45%514.85M-5.16%120.72M10.11%128.04M6.09%130.62M15.82%135.47M2.80%483.67M6.30%127.29M
Gross profit 22.94%557.28M25.16%581.57M13.60%523.65M18.11%1.9B28.09%525.49M16.51%453.29M13.15%464.66M14.55%460.94M17.20%1.61B24.29%410.25M
Operating expense 16.81%443.41M15.54%461.12M11.71%445.19M11.48%1.75B21.13%525.88M-2.80%379.6M7.68%399.09M7.40%398.54M8.02%1.57B10.11%434.15M
Selling and administrative expenses 46.87%253.5M27.62%263.03M7.05%225.91M9.75%937.3M23.89%304.4M-20.39%172.6M4.71%206.1M8.43%211.02M12.46%854M12.91%245.7M
-Selling and marketing expense -10.66%108.9M6.23%122.8M----8.46%488.4M6.90%133.2M9.52%121.9M5.67%115.6M----11.16%450.3M10.17%124.6M
-General and administrative expense 185.21%144.6M54.95%140.23M----11.20%448.9M41.37%171.2M-51.94%50.7M3.51%90.5M----13.94%403.7M15.89%121.1M
Research and development costs -3.35%184.9M3.62%183.79M19.29%204.99M14.96%746.77M19.39%206.25M21.22%191.31M12.12%177.36M6.85%171.85M3.31%649.61M7.24%172.75M
Depreciation amortization depletion -68.06%5.01M-8.48%14.3M-8.76%14.3M-0.96%62.2M-3.03%15.23M-1.38%15.68M0.19%15.62M0.37%15.67M1.45%62.8M0.64%15.7M
-Depreciation and amortization -68.06%5.01M-8.48%14.3M-8.76%14.3M-0.96%62.2M-3.03%15.23M-1.38%15.68M0.19%15.62M0.37%15.67M1.45%62.8M0.64%15.7M
Operating profit 54.52%113.87M83.71%120.45M25.73%78.46M243.96%158.1M98.37%-390K5,102.92%73.69M63.70%65.57M99.20%62.4M161.84%45.96M62.79%-23.9M
Net non-operating interest income expense 26.12%15.09M83.03%16.21M91.97%15.82M1,886.63%41M134.97%11.95M3,637.81%11.96M754.14%8.86M514.90%8.24M142.51%2.06M341.98%5.08M
Non-operating interest income 14.70%18.05M56.87%19.79M62.15%19.37M223.49%58.34M107.16%18.04M214.86%15.74M403.47%12.61M556.21%11.94M72.05%18.03M399.14%8.71M
Non-operating interest expense -21.46%2.97M-4.82%3.57M-4.21%3.55M8.87%16.74M81.47%5.5M-19.23%3.78M-2.69%3.76M-2.71%3.7M4.29%15.38M-6.76%3.03M
Total other finance cost ------------0.17%594K----------------0.00%593K----
Other net income (expense) 768.67%5.46M-25.30%-4.53M181.13%11.27M-110.38%-10.54M518.36%7.78M-15.56%-817K6.08%-3.61M-113.25%-13.89M2,540.41%101.55M529.35%1.26M
Special income (charges) --0--0--10M--0--0--0--0--01,395.00%103.6M64.71%-600K
-Less：Restructuring and merger&acquisition --------------0-----------------45.00%4.4M-64.71%600K
-Gain on sale of property,plant,equipment --0--0--10M--0--0--0--0--0--108M--0
Other non- operating income (expenses) 768.67%5.46M-25.30%-4.53M109.12%1.27M-414.05%-10.54M318.68%7.78M-523.32%-817K-22.60%-3.61M-1,103.38%-13.89M-117.31%-2.05M32.05%1.86M
Income before tax 222.64%134.44M86.61%132.14M85.96%105.55M26.07%188.56M210.08%19.33M2,288.50%41.67M103.18%70.81M-57.70%56.76M298.51%149.58M73.63%-17.56M
Income tax 2,096.82%28.36M69.00%24.96M185.94%16.89M160.99%20.92M93.95%-1.05M-72.81%1.29M105.51%14.77M-55.90%5.91M171.12%8.02M-99.50%-17.31M
Net income 162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K
Net income continuous Operations 162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K
Minority interest income
Net income attributable to the parent company 162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K
Basic earnings per share 166.67%0.5686.67%0.5674.07%0.4717.11%0.898,315.09%0.11625.00%0.21100.00%0.3-59.09%0.27317.14%0.7699.58%-0.0013
Diluted earnings per share 161.90%0.5589.66%0.5570.37%0.4616.00%0.878,315.09%0.11625.00%0.2193.33%0.29-57.14%0.27314.29%0.7599.58%-0.0013
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data